IP 3 binding to IP 3 receptors (IP 3 Rs) at the ER triggers the release of calcium into the cytosol. Calcium and DAG activate PKC. In addition, PLC may deplete its substrate, PIP 2 , which is an activating cofactor for many ion channels and other membrane proteins (Suh and Hille, 2008; Logothetis et al., 2010) . We explore all these actions here.
Intriguingly, the consequences of PIP 2 hydrolysis-(a) calcium release, (b) PKC activation, (c) net PIP 2 depletion, and (d) channel inhibition-do not always occur together. Moreover, most cells harbor several different kinds of receptors coupled to G q , whose signaling responses sometimes differ. For example, in sympathetic neurons, bradykinin (through B 2 receptors) and acetylcholine (through M 1 muscarinic receptors [M 1 Rs]) stimulate production of DAG, but only bradykinin leads to calcium release (Delmas and Brown, 2002) , and only acetylcholine leads to observable PIP 2 depletion (Zaika et al., 2011) . The existence of signaling microdomains and the calcium-induced acceleration of PIP 2 synthesis have been identified as factors contributing to this dissociation in sympathetic neurons (Delmas and Brown, 2002; Zaika et al., 2011) . G q -coupled plasma membrane receptors activate phospholipase C (PLC), which hydrolyzes membrane phosphatidylinositol 4,5-bisphosphate (PIP 2 ) into the second messengers inositol 1,4,5-trisphosphate (IP 3 ) and diacylg lycerol (DAG). This leads to calcium release, protein kinase C (PKC) activation, and sometimes PIP 2 depletion. To understand mechanisms governing these diverging signals and to determine which of these signals is responsible for the inhibition of KCNQ2/3 (K V 7.2/7.3) potassium channels, we monitored levels of PIP 2 , IP 3 , and calcium in single living cells. DAG and PKC are monitored in our companion paper (Falkenburger et al. 2013 . J. Gen. Physiol. http://dx.doi.org/10.1085 . The results extend our previous kinetic model of G q -coupled receptor signaling to IP 3 and calcium. We find that activation of low-abundance endogenous P2Y 2 receptors by a saturating concentration of uridine 5-triphosphate (UTP; 100 µM) leads to calcium release but not to PIP 2 depletion. Activation of overexpressed M 1 muscarinic receptors by 10 µM Oxo-M leads to a similar calcium release but also depletes PIP 2 . KCNQ2/3 channels are inhibited by Oxo-M (by 85%), but not by UTP (<1%). These differences can be attributed purely to differences in receptor abundance. Full amplitude calcium responses can be elicited even after PIP 2 was partially depleted by overexpressed inducible phosphatidylinositol 5-phosphatases, suggesting that very low amounts of IP 3 suffice to elicit a full calcium release. Hence, weak PLC activation can elicit robust calcium signals without net PIP 2 depletion or KCNQ2/3 channel inhibition.
(mM): 175 KCl, 5 MgCl 2 , 5 HEPES, 0.1 K 4 BAPTA, 3 Na 2 ATP, and 0.1 Na 3 GTP, pH 7.4 (KOH). Recordings used an EPC9 amplifier with Patchmaster 2.35 software (HEKA). Currents were filtered at 2.9 kHz. Sample intervals were 200 µs or slower. Series resistance was compensated by 70% after compensation of fast and slow capacitance. Leak was not subtracted. Holding potential was 60 mV. KCNQ2/3 current was quantified by measuring tail currents. Every 2 s, the membrane was depolarized to 20 mV for 400 ms and repolarized to 60 mV. KCNQ2/3 current activates slowly upon depolarization and deactivates slowly upon repolarization (see Fig. 1 A, bottom right). KCNQ2/3 tail currents were measured by comparing current at 20 and 400 ms after repolarization to 60 mV.
For perforated-patch recordings, amphotericin B was dissolved in DMSO on the day of recording (1 mg/10 µl), sonicated, diluted in internal solution to a working concentration of 300-500 µg/ml, and sonicated again. The tip of the patch pipette was filled with amphotericin B-free Ringer's solution by capillary action. After <5 min, access resistance was usually low enough to record KCNQ2/3 current.
Perfusion, extracellular buffer, and temperature Cells were recorded in a 100-µl chamber continuously superfused (1 ml/min) with Ringer's solution containing (mM): 160 NaCl, 2.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 8 glucose, pH 7.4 (NaOH). All drugs were applied in the superfusate. As a measure of exchange time, when 2.5 mM KCl Ringer's solution was replaced by 30 mM KCl Ringer's solution (shifting the K + reversal potential positive of 60 mV), KCNQ2/3 tail currents were inverted with a delay of <1 s and a time constant of 2 s, which is sufficiently fast for the kinetics investigated here. All measurements reported in this paper were done at room temperature, 21-23°C.
Photometric calcium measurements
All optical measurements of calcium and FRET used a monochromatic light source (Polychrome IV; TILL Photonics) for epifluorescence illumination and one or two TILL photodiodes with suitable filters and dichroic mirrors for photometry. Photodiode voltages were acquired by Patchmaster (sampling 200 µs or slower), and after recording from each cell, an area of the coverslip without cells was measured as background. Cytosolic free calcium was measured with the low-affinity indicator Fura-4F (Invitrogen). For measurements without electrophysiology or in perforated-patch configuration, cell-permeable Fura-4F-AM ester was diluted to 2 µM in Ringer's solution supplemented with 0.2% pluoronic F-68. Cells were loaded for 40 min and then incubated in regular Ringer's solution for an additional 30 min to allow complete de-esterification of AM esters. For measurements in whole-cell configuration, 0.1 mM of cell-impermeable Fura-4F salt was added to the intracellular solution in the patch pipette. Fura-4F fluorescence was measured by stepping the excitation light to 340 nm for 100 ms and 380 nm for 20 ms every 4 s. (The recording time with 340-nm excitation was longer than for 380-nm excitation to compensate for the poorer signal-to-noise ratio with 340-nm excitation.) Excitation light was reflected by a 415-dclp or a three-color (89006bs; Chroma Technology Corp.) dichroic mirror. Fluorescence was detected using one photodiode with a 535/30-nm emission filter. Background fluorescence was subtracted, and the ratio of emission with 340-nm excitation (F 340 ) to emission with 380-nm excitation (F 380 ) was calculated offline using a custom macro for IGOR Pro 6.0 (WaveMetrics).
The following features were extracted from traces of Fura-4F ratio (F 340 /F 380 ): baseline, mean ratio of the points preceding agonist application; peak, the maximum ratio reached within 20 s after agonist application; time to half-maximum, the delay between start of agonist application and the first time point where We believe that knowing the quantitative requirements for PKC activation, calcium response, and PIP 2 depletion will be valuable for understanding how such signaling specificity can work, how PLC activation can lead to calcium release but not PIP 2 depletion, and how the effects of PLC activation through M 1 R can differ from those of PLC activation through other G q PCRs. Therefore, we performed a quantitative analysis of signaling events downstream of PLC, using fluorescent reporters for PIP 2 , IP 3 , and calcium, and in Falkenburger et al. (2013) for DAG and PKC. In that paper, these measurements are then used to extend a kinetic model of PLC signaling that builds on earlier versions (Horowitz et al., 2005; Falkenburger et al., 2010a,b) . We show, for instance, that the requirements for calcium release and KCNQ2/3 channel inhibition are quite different: calcium release can be evoked with a far lower density of activated receptors.
M A T E R I A L S A N D M E T H O D S
Cell culture and plasmids tsA-201 cells were cultured in DMEM (Gibco) with 10% serum and 0.2% penicillin/streptomycin and passaged every 5 d. Cells were transiently transfected at 75% confluency with Lipofectamine 2000 (10 µl for a 3-cm dish; Invitrogen) and 0.5-1.2 µg DNA per plasmid. Cells were transfected 1 or 2 d before photometry experiments and 2 d before patch-clamp experiments. Cells were plated on polylysine-coated glass chips 12 h before experimentation.
The following plasmids were used: dark (nonfluorescent) and eYFP-labeled mouse M 1 R (M 1 R and M 1 R-YFP; provided by N. Nathanson, University of Washington, Seattle, WA); human purinergic receptor P2Y 2 (P2Y 2 R; The Missouri S&T cDNA Resource Center); EPAC1 (exchange protein directly activated by cAMP) Förster resonance energy transfer (FRET) probe for cAMP (provided by M. Lohse, University of Würzburg, Würzburg, Germany); human KCNQ2 (provided by D. McKinnon, State University of New York, Stony Brook, NY); human KCNQ3 (provided by T. Jentsch, Leibniz-Institut für Molekulare Pharmakologie, Berlin, Germany); eCFP-PH(PLC1), eYFP-PH(PLC1), and CFP-CAAX (from K-Ras; provided by K. Jalink, The Netherlands Cancer Institute, Amsterdam, Netherlands); the zebrafish voltage-sensitive phosphatase Dr-VSP-IRES-GFP (Dr-VSP; provided by Y. Okamura, Osaka University, Osaka, Japan); "Dark" Dr-VSP (Falkenburger et al., 2010b) ; and the IP 3 reporters IRIS-1 (provided by K. Mikoshiba, Institute of Physical and Chemical Research Brain Science Institute, Wako, Japan) and LIBRA version III (LIBRAvIII; provided by A. Tanimura, Health Sciences University of Hokkaido, Tobetsu, Japan). IRIS-1 is cytosolic, whereas LIBRAvIII is membrane localized by palmitoylation (membrane-targeting sequence of GAP43). Version III of LIBRA has the pH-stable YFP mutant Venus instead of eYFP and derives from rat IP 3 R type III. The small interfering RNA (siRNA) for P2Y 2 was purchased from Santa Cruz Biotechnology, Inc. Membrane-targeted FRB (LDR) and CFP-FKBP-Inp54p were generated by T. Inoue (Johns Hopkins University, Baltimore, MD) and described previously (Suh et al., 2006) . Hereafter, we refer to fluorophores simply as "CFP" or "YFP" regardless of whether regular or enhanced fluorescent proteins were used. Electrophysiology KCNQ2/3 currents were recorded in whole-cell gigaseal voltageclamp or perforated-patch configuration using borosilicate glass pipettes with a resistance around 2.2 MΩ. Internal solution was Laboratories, Inc.) was coupled to horseradish peroxidase and visualized by chemiluminescence using a digital imaging system (AlphaImager; AlphaInnotech). Bands were quantified by measuring the mean intensity in each lane with the same-sized region of interest. Results from four independent experiments were averaged for display. Results did not change when intensities for P2Y 2 were normalized to amounts of actin as a loading control.
Modeling
To summarize the results and test mechanistic hypotheses, a kinetic model of G q PCR signaling was formulated and solved in the Virtual Cell simulation environment (University of Connecticut Health Center). Results of the model appear in many figures of this paper, but the rationale, design, and parameters of the model itself are described only in our companion paper (Falkenburger et al., 2013) .
Statistics
Summarized data include one data point per cell. Numbers, bars, and markers represent mean ± SEM. The notation n = xx refers to the number of cells averaged unless otherwise noted. Comparisons were made by one-way ANOVA and Tukey posthoc tests using GraphPad Prism software.
Online supplemental material Fig. S1 shows that uridine 5-triphosphate (UTP) does not inhibit KCNQ2/3 currents in whole-cell configuration. In Fig. S2 , endo genous P2Y receptors change calcium but not cAMP. Fig. S3 shows expression patterns of FRET probes/pairs. Fig. S4 is a comparison of the IP 3 FRET probes LIBRAvIII versus IRIS-1. Fig. S5 shows modeling related to IP 3 and LIBRAvIII. In Fig. S6 , time course of PIP 2 (PH-domain FRETr) during intermittent voltagesensitive 5-phosphatase (VSP) activation is shown. Fig. S7 shows calcium rise in response to caffeine and ryanodine. Fig. S8 shows the origin of the plateau in the calcium and Fura-4F responses, and in Fig. S9 , the time course of acceleration of PIP 2 synthesis is established. Figs. S1-S9 are available at http://www.jgp.org/cgi/ content/full/jgp.201210886/DC1.
R E S U L T S

Activation of endogenous P2Y receptors evokes calcium release but not significant PIP 2 depletion
To gain insight into the IP 3 branch of signaling elicited by activation of G q PCR and PLC, we monitored levels of PIP 2 , IP 3 , and calcium by optical probes and recorded KCNQ2/3 potassium currents in single living tsA-201 cells. The overall design was to compare responses with a purinergic agonist to those with a muscarinic agonist in cells transfected with M 1 Rs. tsA-201 cells do not express endogenous M 1 Rs. We previously measured both endogenous and overexpressed levels of components of the M 1 R signaling cascade (Falkenburger et al., 2010a) and estimated the density of overexpressed M 1 Rs as being several orders of magnitude higher (500-1,000 per µm 2 ) than typical estimates of endogenous receptors (1 per µm 2 ) such as endogenous purinergic receptors. Henceforward, we refer to transfected M 1 Rs as "high-density" M 1 Rs.
First, we measured calcium using Fura-4F. Despite the large expected difference in their receptor densities, we found that the Fura-4F response was similar when the ratio exceeded 50% of the distance between baseline and peak; duration, the delay between time to half-maximum and the first time point when the ratio fell below 10% of the distance between baseline and peak. (The level of 10% was chosen to include a late "hump" or plateau of the Fura-4F signal in response to G q PCR activation.)
Three methods for obtaining Fura-4F calibration curves were compared: (1) adding Fura-4F salt to solutions with known calcium concentrations and measuring droplets of these solutions, (2) measuring cells into which such solutions had been dialyzed by the whole-cell pipette, and (3) superfusing cells loaded with cell-permeable Fura-4F/AM with such solutions in the presence of 15 µM ionomycin. These calibrations yielded similar results. The calcium concentration corresponding to a given r = F 340 /F 380 is given by: [calcium] = K (r  r min )/(r max  r), where r min is F 340 /F 380 with 20 mM EGTA and r max is F 340 /F 380 with 2 mM calcium. Values of rmin and rmax were dependent on the dichroic mirror used in the microscope. The "triple dichroic" we used to measure FRET (89006bs; Chroma Technology Corp.) reflects short wavelength excitation light slightly less well than a dichroic mirror designed specifically for Fura measurements (DCLP 415). Accordingly, rmin and rmax were 0.017 and 0.245 for the 89006bs, and 0.050 and 0.737 for the DCLP 415. The calcium concentration at which the F340/F380 ratio change is half-maximal was K = 30 µM, regardless of the dichroic used. 89006bs was used for experiments as in We chose a low-affinity calcium indicator to better discriminate higher levels of cytosolic free calcium. Using such an indicator means that it is difficult to resolve low levels of resting calcium properly. It is for this reason that the figures show fura ratio F 340 /F 380 .
Photometric FRET measurements
Epifluorescence photometry measured FRET from CFP to YFP using a three-color dichroic mirror in the microscope, two photodiode detectors, and the excitation wavelength scanned in a ramp as described in Falkenburger et al. (2010b) . Unless otherwise noted, sweeps were repeated every 2 s. The raw fluorescence data were corrected for background and for bleedthrough of CFP emission into the YFP recording channel, yielding the corrected fluorescence values CFP C (480/40-nm emission with 440-nm excitation) and YFP C (535/30-nm emission with 440-nm excitation). As before, FRET was expressed as the ratio FRETr = YFP C /CFP C . CFP C , YFP C , and FRETr are in arbitrary, apparatus-dependent units. In two panels as indicated, the points were mildly smoothed with a binomial filter that weighted immediate neighbors by a 0.25/ 0.5/0.25 algorithm.
For time courses of FRETr responses, we determined the following: baseline, mean FRETr of the points preceding agonist application; amplitude, the difference in FRETr between baseline and maximum or minimum for the response, the delay from agonist application to the onset of the response, and the exponential time constant of the rising and falling phases of the signal (by the fitting procedure of Jensen et al., 2009) ; and the duration at half-maximum.
Western blot
Cells were harvested in ice-cold PBS, centrifuged, and resuspended in 50 µl of lysis buffer (PBS with 1% Triton X-100, 1:100 EDTA, and protease inhibitor cocktail; Thermo Fisher Scientific). Lysates were incubated for 30 min on ice, triturating regularly. Lysates were cleared by centrifugation (13,000 g for 20 min at 4°C), and the supernatant was transferred to new tubes. 20 µg of protein was separated by SDS-PAGE using standard techniques (Falkenburger et al., 2010a) . The primary antibody against human P2Y 2 (Santa Cruz Biotechnology, Inc.) was used at 1:500. The secondary antibody (1:30,000; goat anti-rabbit; Kirkegaard & Perry whole-cell calcium response with UTP could be a consequence of (a) diffusion of IP 3 and calcium into the patch pipette, thereby reducing IP 3 -and calcium-induced calcium release, and/or (b) an inhibitory effect of Mg 2+ diffusion into the cell (Volpe et al., 1990) .
The contrast between responses of P2Y receptors and M 1 Rs thus raises a challenging question: How do two receptors produce a full-amplitude calcium signal, whereas only one of them inhibits KCNQ2/3 channels? To address this, we first identified the endogenous subtype of P2Y receptors in tsA-201 cells.
P2Y 2 R is the major endogenous G q PCR responsible for UTP-activated calcium rises tsA-201 cells express P2Y receptor subtypes 1, 2, 11, 12, and 14 (Atwood et al., 2011) . Of these, only P2Y 2 R and P2Y 11 R are directly activated by UTP. Both use G q as their primary transduction pathway, with P2Y 11 R also using G s as a secondary transduction mechanism. We found that UTP does not produce a detectable change in cAMP levels as measured by a FRET sensor based on EPAC (Nikolaev et al., 2004; Fig. S2 ), suggesting that P2Y 2 R would more likely be the major endogenous receptor responsible for rises in cytosolic calcium. In the following experiments, we confirmed the expression and functional importance of P2Y 2 R in tsA-201 cells by (a) Western blot analysis, (b) testing the effects of a P2Y 2 R antagonist, and (c) P2Y 2 R "knockdown" by an established siRNA.
we activated endogenous purinergic receptors using a saturating concentration of 100 µM UTP or activated high-density M 1 Rs using 10 µM oxotremorine-M (Oxo-M; Fig. 1, A and B) . In perforated-patch recording with either stimulus, the Fura-4F ratio (F 340 /F 380 ) rose to values corresponding to 1-3 µM of free calcium. On average, the amplitude of the Fura-4F response to UTP was 98% of the Oxo-M response ( Fig. 1 C) , and the duration of the response (50-10% of maximum) was similar ( Fig. 1 D) . However, the UTP response did rise more slowly, taking approximately three times as long to reach half-maximal amplitude ( Fig. 1 E) , suggesting that the activation of G q and PLC by UTP was less intense. The ambient resting calcium was below the threshold for reliable quantitation by the low-affinity Fura-4F dye.
When we recorded KCNQ2/3 potassium currents in the perforated-patch configuration simultaneously with Fura-4F signals, we were surprised to find that KCNQ2/3 currents were not inhibited by 100 µM UTP although they were inhibited by 10 µM Oxo-M ( Fig. 1, A and F) . The findings were similar in whole-cell configuration (Fig. S1 , A and B), with <1% inhibition by UTP (22 cells) and 84% inhibition by Oxo-M (17 cells). Under the perforated-patch configuration, peak current was gradually growing (spontaneously) in some cells, sometimes leading to apparent "negative" values of inhibition by agonist. We show perforated-patch configuration in Fig. 1 because UTP did not elicit a calcium response in wholecell configuration (Fig. S1, A and B) . The absence of a High-density P2Y 2 R can evoke PIP 2 depletion and KCNQ2/3 current inhibition To understand the apparent differences between P2Y 2 R and M 1 R actions, we next compared their effects on plasma membrane PIP 2 . The PIP 2 levels were monitored as FRET between fluorescently tagged PIP 2 -binding pleckstrin homology (PH) domains from PLC 1 (van der Wal et al., 2001) . Binding to PIP 2 at the plasma membrane brings CFP-PH and YFP-PH close enough together for FRET to occur. When PIP 2 is depleted, the PH domains translocate to the cytosol, and as the average distance between them increases, FRET decreases ( Fig. 3 A) . The first experiments compared high-density M 1 R with lowdensity eP2Y 2 R. Similar to our previous studies (Jensen et al., 2009; Falkenburger et al., 2010a) , FRETr from the PH domain reporter of PIP 2 fell to 50% of the initial value with the application of 10 µM Oxo-M ( Fig. 3, B-D) , indicating a strong depletion of PIP 2 . In contrast, FRETr did not decrease significantly upon the application of 100 µM UTP (Fig. 3, B and D). Thus, we observed similar calcium responses to eP2Y 2 R and M 1 R activation but saw PIP 2 depletion and KCNQ2/3 inhibition only with M 1 R activation. We infer that the significant calcium rise observed with UTP neither suffices to induce net PIP 2 depletion (by, for example, activating PLC) nor to inhibit KCNQ2/3 current by itself.
Because of the difference in receptor densities between M 1 R and eP2Y 2 R, we hypothesized that a higher Protein lysates from tsA-201 cells probed with a primary antibody against P2Y 2 R revealed two bands, one at a molecular mass of 50 kD and the second at 100 kD ( Fig. 2 A) . We assume that they represent receptor monomers (predicted protein M r 41 kD) and dimers. Lysates from populations of cells transfected with human P2Y 2 R showed greatly increased P2Y 2 R expression (both bands) and had to be diluted 100 times to produce bands of similar intensity to endogenous P2Y 2 R. We conclude that on average, transient overexpression increases P2Y 2 R by 100-fold. Presumably it is increased even more than the 100-fold mean in some individual well-transfected cells (see Falkenburger et al., 2010a) . Transfecting siRNA against P2Y 2 R decreased the intensity of the endogenous receptor bands by 90% ( Fig. 2 A) . The siRNA was also effective at reducing the augmented expression of transfected P2Y 2 R RNA ( Fig. 2 A) . Likewise, compared with control ( Fig. 2 B) , the P2Y 2 R siRNA decreased the peak amplitude of the UTP-evoked calcium rise by 90% in cells expressing only endogenous receptors, and it decreased the peak by 65% in P2Y 2 -transfected cells (Fig. 2 , C-E). 100 µM suramin, a P2Y 2 R antagonist, reduced the UTP-evoked calcium response by 68% ( Fig. 2 F ; n = 5). These separate lines of evidence indicate that the endogenous receptor activated by UTP is P2Y 2 . Hereafter, we refer to endogenous P2Y 2 Rs as (low-density) "eP2Y 2 R," and the combination of overexpressed and endogenous P2Y 2 Rs as (high-density) "oP2Y 2 R". (E) Summary of UTP-induced calcium responses after siRNA transfection (n = 6 for control, n = 8 for siRNA, and n = 5 for overexpression and siRNA). (F) Calcium responses in a cell exposed to the P2Y 2 R antagonist suramin (100 µM). Representative of n = 7 cells. spare receptors, the receptor reserve, is large for calcium release and smaller for KCNQ2/3 inhibition and PIP 2 depletion.
These findings demonstrate that agonist and receptor requirements can differ between different outputs of G q -coupled signaling and suggest the hypothesis that the differences we see between P2Y 2 R and M 1 R actions might be explained entirely by a difference in receptor density. Our companion paper (Falkenburger et al., 2013 ) describes a mathematical, kinetic model based on this hypothesis that reproduces most of the features we have seen. Figs. 4 (C and D) and 5 (A and B) in this paper show simulations from that model. With appropriate choices of parameters, an increase in receptor density from 1 to 500 per µm 2 converts a response with little depletion of PIP 2 or decrease of current, yet still a strong Ca 2+ rise and Fura-4F response (Fig. 5, A and B , "UTP"), into a response with the typical full Fura-4F signal, full inhibition of KCNQ current ( Fig. 5 A, "Oxo-M"), strong Ca 2+ increase, and full depletion of PIP 2 (Fig. 5 B , "Oxo-M"). The same calculations show that very low concentrations of agonist still evoke a full-amplitude Fura-4F response and a strong Ca 2+ transient when receptor density is high (Fig. 4, C and D) . density of activated receptors is needed to deplete PIP 2 and to inhibit KCNQ2/3 currents than to induce calcium release. To test this hypothesis, we modified receptor density and receptor occupancy independently. First, we increased the total density of P2Y 2 R by overexpression, which, based on Western blot analysis, increased the density at least 100-fold (Fig. 2 A) . In such cells with high-density P2Y 2 R, 100 µM UTP did reduce PH domain FRETr (Fig. 3, C and D) and inhibit KCNQ2/3 current (Fig. 3, E and F) to a similar extent as Oxo-M acting through high-density M 1 R. Second, we lowered the concentration of Oxo-M to reduce M 1 R occupancy. Even a very low concentration of Oxo-M (1 nM) elicited a Fura-4F signal of similar size and duration as 10 µM Oxo-M (Fig. 4, A and B) , although the time to half-maximum was longer with low Oxo-M concen trations. Previous work showed no reduction in PH-domain FRETr and no inhibition of KCNQ2/3 with 1 nM Oxo-M (Jensen et al., 2009 ). Thus, with high-density M 1 Rs, more agonist is required to inhibit KCNQ2/3 and to deplete PIP 2 than to release calcium. In pharmacological terms, the 50% effective concentration for calcium release is much lower than that for KCNQ2/3 inhibition; i.e., the number of 550 nM IP 3 for IRIS-1 and 490 nM for LIBRAvIII. These probes are insensitive to physiological changes of calcium. In our hands, IRIS-1 signals were difficult to interpret and were not graded with Oxo-M concentration. On average, the IRIS-1 response is an 15% FRET decrease with invariant temporal characteristics in response to 1 nM, 100 nM, and 10 µM Oxo-M (Fig. S4, A and B , and not depicted). Further, with 10 µM Oxo-M, the delay before onset, the onset and recovery time constants, and the IRIS-1 response duration were longer than expected from our calcium measurements or from reported biochemical assays of IP 3 (Willars et al., 1998) ,
Receptors stimulate IP 3 production
To identify at which stage of the G q signaling cascade the receptor reserve arises, we measured IP 3 production in living tsA-201 cells using two FRET reporters, IRIS-1 (Matsu-ura et al., 2006) and LIBRAvIII (Tanimura et al., 2009 ). Both consist of CFP and YFP linked by the ligandbinding domain of the rat IP 3 R type III. They show a reduction in FRET between CFP and YFP upon binding of IP 3 . IRIS-1 is a cytosolic protein, whereas LIBRAvIII is targeted to the plasma membrane by a palmitoylation sequence from GAP43 (Fig. S3 ). The reported ligand concentrations for half-maximal FRET change are similar: understand the dialysis protocol better, the entry of IP 3 was simulated by adding to our larger cell model a first-order exchange from the pipette through a ratelimiting orifice. This model reproduced the calibration experiment reasonably well (lines in Fig. 6 B) , assuming a dissociation constant of 500 nM for the IP 3 -LIBRA complex as reported by others (Tanimura et al., 2009) . The model indicates that the endogenous steady-state IP 3 5-phosphatase activity, which allows a mean lifetime for IP 3 of only 12.5 s, severely reduces the cellular IP 3 during dialysis. Separate control experiments (not depicted) with fluorescent dyes in the pipette typically showed dialysis of dye into the cytosol with an exponential time constant of 50-70 s. With similar pipette exchange rates for IP 3 added to the model and retaining an active endogenous IP 3 phosphatase, the steady-state cytosolic IP 3 concentration reaches only roughly 20% of that in the pipette, and the time constant of the exponential change is only 20% of that with and much longer than those observed with LIBRAvIII. Possible explanations for such unexpected kinetics include reporting of IP 3 in cellular regions far from the plasma membrane.
We therefore turned to membrane-localized LIBRAvIII. It responded to 10 µM Oxo-M with a small, reproducible FRETr decrease (Fig. 6 A) . The IP 3 selectivity was assessed by overexpressing the enzyme IP 3 5-phosphatase, which can deplete IP 3 as fast as it is made in these cells (Horowitz et al., 2005) . Overexpression of this enzyme eliminated the responses of LIBRAvIII (Fig. 6 A) , confirming the FRET probe's selectivity for IP 3 . We calibrated the probe by dialyzing different concentrations of IP 3 into the cell via a patch pipette ( Fig. 6 B,  circles) . Time-dependent FRET changes began in <10 s after breakthrough. No detectable change in FRETr occurred with dialysis of 1 µM IP 3 , whereas the response nearly saturated with dialysis of 10 µM IP 3 . Thus, the LIBRAvIII probe has a fairly narrow dynamic range. To the IP 3 calibration experiments, we found that 10 µM Oxo-M elicited responses similar in amplitude and kinetics to dialysis with 10 µM IP 3 in the pipette. The IP 3 -binding curve of LIBRAvIII (Fig. S5 C) shows that LIBRAvIII does not discriminate well between IP 3 concentrations above 2 µM. We conclude that peak IP 3 is above 2 µM. The resting levels of IP 3 are below the level reached with 2 µM IP 3 in the pipette (<300 nM in the cell), which evoked a minimal FRETr decrease. Fig. 6 (E and F) shows that the dependence of the LIBRAvIII response amplitude, rise time, and duration on Oxo-M concentration was captured qualitatively in the kinetic model described in our companion paper (Falkenburger et al., 2013) . In this model, free IP 3 rises to 10 µM in the absence of LIBRAvIII. This limit would result from cleavage of nearly all of the cellular PIP 2 . no cytosolic phosphatase (see Fig. S5 A) . In addition LIBRAvIII significantly buffers the IP 3 (see Fig. S5 B) .
LIBRAvIII responded to G q PCR activation in a dosedependent manner. No response was detected with 1 nM Oxo-M, whereas with 100 nM or 10 µM Oxo-M the amplitudes were not statistically different, which is consistent with the narrow dynamic range observed during IP 3 dialysis. However, the time courses differed (Fig. 6,  C and D) . Comparing responses to 100 nM versus 10 µM Oxo-M, the delay before onset was longer (18 ± 2 s vs. 9 ± 6 s), the onset slower ( on 7 ± 1 s vs. 3 ± 1 s), and the duration shorter (40 ± 3 s vs. 72 ± 10 s; Fig. 6 D) . The slower response and faster recovery are expected from the weaker activation of PLC by 100 nM Oxo-M (Jensen et al., 2009) .
What is the range of IP 3 changes? When the Oxo-M responses of LIBRAvIII were compared with those in Figure 7 . A little IP 3 suffices to initiate robust calcium signals. (A) Time course of calcium responses (Fura-4F) to UTP application. Cells were transfected with plasma membranetargeted FRB and the PIP 2 5-phosphatase CFP-FKBP-Inp54p for recruitment of the 5-phosphatase to the plasma membrane by 5 µM rapamycin (bar). Representative of n = 5 cells. (B) Simulations from our kinetic model of the observations in A. A second calculation starts at 500 s in which a supplemental 5-phosphatase activity is turned on. Note that as PIP 2 gradually falls to a new steady state, less resting IP 3 is made by the basal PLC activity (a function of basal nucleotide exchange at G), and basal calcium release declines, slowly decreasing resting Fura-4F saturation. (C) Simultaneous recording of KCNQ2/3 tail current (bottom) and cytosolic calcium by Fura-4F ratio (top). Cells were transfected with M 1 R, KCNQ2/3 channels, and the VSP. During baseline, KCNQ2/3 channels were activated maximally by depolarization from 60 to +40 mV for 200 ms every 600 ms. During the shaded rectangle marked "VSP," depolarization to +120 mV activated KCNQ2/3 channels as well as VSP, which depleted PIP 2 by 80% within seconds. Then, 10 µM Oxo-M was applied. The resulting calcium response was compared with calcium responses elicited before VSP-induced PIP 2 depletion. 2006). However, this manipulation did not reduce the amplitude of subsequent calcium responses to UTP (Fig. 7 A) . The model also shows a resistance of the calcium response to 90% depletion of PIP 2 (Fig. 7 B) . A second approach used a VSP to deplete PIP 2 and gave the same result (Fig. 7 C) . Depolarization activates VSP reversibly and depletes plasma membrane PIP 2 (Murata and Okamura, 2007; Falkenburger et al., 2010b) . PIP 2 levels were continuously monitored by recording KCNQ2/3 currents. To record KCNQ2/3 currents while keeping PIP 2 levels low over tens of seconds in VSPtransfected cells, we stepped cyclically from a holding potential of 60 to +120 mV for 400 ms, every 800 ms, and measured KCNQ2/3 tail currents at 60 mV. On average, the intermittent depolarization to +120 mV was sufficient to reduce KCNQ2/3 current by 80%. The time course of PIP 2 reduction as reported by PH-domain FRET was saw-toothed with an overall relaxation time constant of 10 s (Fig. S6 ). Despite this accumulating PIP 2 depletion, 10 µM Oxo-M could still evoke a full-amplitude calcium response (Fig. 7 C) . Because the KCNQ2/3 current reduction achieved by the intermittent depolarization to +120 mV varied with VSP expression levels, we grouped the recorded cells by the extent of KCNQ2/3 inhibition for quantification (Fig. 7, E and F) . Simulations from our kinetic model show that when VSP activity was adjusted to give a 90% reduction in KCNQ2/3 current, 10 µM Oxo-M generated a calcium response of similar amplitude but reduced duration (Fig. 7 D) , similar to our experimental data (Fig. 7, E and F) . In summary, activation of PLC can generate sufficient IP 3 for a calcium response even when PIP 2 levels are only a fraction of normal. It should be emphasized that the two 5-phosphatase treatments we used do lower PIP 2 considerably but never to zero because PIP 2 synthesis continues.
A low threshold for IP 3 -dependent calcium release
We now turn to Ca 2+ release from the ER. To learn the kinetic relation of IP 3 production to calcium release, we overlaid normalized experimental Fura-4F and LIBRAvIII responses for 10 µM Oxo-M (Fig. 6, G and H) . LIBRAvIII reports a rise in IP 3 beginning already at 2 s, whereas the sudden upstroke of the Fura-4F signal occurs only between 4 and 6 s (Fig. 6 G) . Hence, LIBRAvIII is a fast reporter of IP 3 , and IP 3 production starts early. However, once initiated, the resulting calcium response rises more rapidly and peaks sooner than the IP 3 signal (Fig. 6 G) . The Ca 2+ rise, in particular its stereotypical amplitude and the concentration-dependent time to half-maximum ( Fig. 4 B) , is nearly like a regenerative response, rising abruptly with positive feedback when graded IP 3 accumulation reaches a certain level. The decay time courses for calcium and IP 3 are quite different ( Fig. 6 H) , reflecting their mechanistically separate clearance mechanisms.
Despite the strong Fura-4F signal produced by 1 nM Oxo-M ( Fig. 4 A) , the amount of IP 3 made at that low agonist concentration is too small to be reported by LIBRAvIII (Fig. 6 C) . A minimal production of IP 3 suffices to initiate the calcium transient. This conclusion was reinforced by experiments showing little change of calcium responses upon reducing the available PIP 2 with coexpressed PIP 2 5-phosphatases. Such prior PIP 2 depletion ought to reduce the amount of IP 3 that can be produced by a given stimulus. First, we used rapamycin-induced dimerization of an FKBP domain with an FRB domain to "activate" the PIP 2 5-phosphatase Inp54p. When FKBP-tagged Inp54p is expressed together with plasma membrane-targeted FRB, the addition of rapamycin leads to translocation of the phosphatase to the plasma membrane and strong PIP 2 depletion (Suh et al., Figure 8 . PIP 2 synthesis is required for maintained IP 3 production. To determine whether PIP 2 is synthesized during G q activation, we inhibited PI 4-kinases by 30 µM wortmannin during a prolonged application of Oxo-M (200 s at 10 µM) and measured IP 3 production by LIBRAvIII. Cells were exposed to wortmannin for 5 min before start of recording. (A and B) Time course of normalized LIBRAvIII responses (control, n = 8 cells; wortmannin, n = 5). (C and D) Simulations from model. In C, the PI 4-kinase reaction was accelerated during agonist appli ca tion with the "standard" time course shown in Fig. S9 A. In D, the PI 4-kinase was either left unchanged at its resting rate or turned off fully so that only the PIP 2 already present at rest is available to generate IP 3 . To achieve a stable baseline with PI 4-kinase off, the PI 4-phosphatase reaction was turned off as well in this case.
Our measurements show that endogenous P2Y 2 Rs are at least 100-fold less abundant than over expressed P2Y 2 Rs, and our modeling shows that a 100-500-fold difference in receptor density between endogenous P2Y 2 Rs and overexpressed M 1 Rs is sufficient to explain all observations. In support, decreasing the number of activated M 1 Rs by using an extremely low concentration of agonist (1 nM Oxo-M) mimics the responses to endo genous P2Y 2 R activation by a saturating concentration of UTP. Conversely, increasing the number of P2Y 2 Rs by overexpression makes the effects of UTP mimic those of Oxo-M. The density of endogenous purinergic receptors that we estimate is in a range expected from our previous estimate of endogenous G proteins and a typical ratio of G proteins to receptors (Falkenburger et al., 2010a) . We therefore attribute the observed differences between UTP and Oxo-M primarily to a difference in receptor numbers. Such obser vations illustrate how quantitative differences in the abundance of a signaling component can result in apparent qualitative differences in responses.
Comparison with neurons
In sympathetic neurons, activation of M 1 Rs leads to PIP 2 depletion (Zaika et al., 2011) , and activation of B 2 receptors leads to calcium release (Delmas and Brown, 2002) . Based on the findings described here, the first observation might be explained by a high density of M 1 Rs and a low density of B 2 receptors in these neurons. Of course, receptors can be arranged in more interesting ways than just being high or low density, particularly in differentiated cells with specialized membrane compartments (e.g., spines, cilia, microvilli, or the apical membranes of epithelia). What counts for downstream effects is not the overall density of receptors but the local density "seen" by PLC molecules. Our data in tsA201 cells suggest that we do not need many PLC molecules (10 per µm 2 ) to fully deplete PIP 2 with the time course and concentration dependence observed experimentally. The interaction of signaling molecules will be strongly affected by inhomogenous densities resulting from membrane compartmentalization and scaffolding molecules. Nonetheless, we believe that the estimates for affinities and binding kinetics between M 1 R, G q , and PLC derived from our previous experiments and modeling (Jensen et al., 2009; Falkenburger et al., 2010a,b) are accurate and similarly apply to sympathetic neurons. Consequently, we have to assume at least 10 µm 2 molecules of PLC to deplete PIP 2 in sympathetic neurons and a density of M 1 R that is high, at least in the vicinity of PLC.
It is not unexpected that low-density B 2 receptors can lead to calcium release, but it is hard to explain why M 1 Rs do not. Others have suggested that B 2 receptors are close to IP 3 Rs and M 1 Rs are not, and that fast IP 3 degradation prevents its diffusion from M 1 R-activated PLC to IP 3 Rs (Delmas et al., 2004) . Expanding measurements Ongoing PIP 2 synthesis is required for continual IP 3 production Is there significant synthesis of PIP 2 during agonist application? Throughout a 200-s application of 10 µM Oxo-M, IP 3 remained elevated, with some possible sag after an initial peak ( Fig. 8 A) . Given that (a) the lifetime of IP 3 is short (Fig. 6) and (b) PIP 2 is depleted by 90% during 10 µM Oxo-M (Horowitz et al., 2005) , this continued production of IP 3 implies that new precursor PIP 2 is being formed as PLC is breaking it down. The rate-limiting step in PIP 2 synthesis is the PI 4-kinase activity; the PIP 5-kinase activity that makes PIP 2 from PI(4)P is 20 times faster (Falkenburger et al., 2010b) . The slow step is probably accelerated during agonist application (Xu et al., 2003; Falkenburger et al., 2010b) .
To determine the importance of de novo PIP 2 synthesis during Oxo-M stimulation, we inhibited the PI 4-kinase using 30 µM wortmannin. After wortmannin, the initial amplitude of the LIBRAvIII FRETr response to Oxo-M was normal, but then it relaxed back to baseline while Oxo-M was still present (Fig. 8 B) : IP 3 production had stopped. Fig. 8 (C and D) shows that a model with accelerated PIP 2 synthesis during Oxo-M application can explain maintained IP 3 elevation throughout Oxo-M application, and that continued IP 3 production fades if PI 4-kinase is not accelerated or is turned off fully.
D I S C U S S I O N
To provide a more complete description of signaling by two different G q -coupled receptors, we have performed quantitative kinetic measurements of PIP 2 , IP 3 , calcium, and KCNQ2/3 channel current in response to agonist application. Our measurements in tsA-201 cells show that (a) endogenous P2Y 2 Rs activate the PLC pathway and signal to KCNQ channels much less effectively than M 1 Rs expressed at high density; (b) experimentally, these differences are largely removed when P2Y 2 Rs are expressed at high density; (c) very little IP 3 needs to be generated to induce a robust calcium release; (d) less receptor stimulation is needed to elicit a Ca 2+ elevation than to deplete PIP 2 or to inhibit KCNQ channels; and (e) accelerated PIP 2 synthesis probably boosts IP 3 production during long receptor activation. These measurements further guided and are explained by an expanded kinetic model detailed in our companion paper (Falkenburger et al., 2013) .
Differences between P2Y 2 Rs and M 1 Rs
We first revisit the contrasting actions of endogenous P2Y 2 Rs and high-density M 1 Rs. A saturating concentration of UTP acting on eP2Y 2 Rs leads to calcium release without inhibition of KCNQ2/3 channels, whereas a saturating concentration of Oxo-M acting on high-density M 1 Rs does both. Nevertheless, we conclude that there is no qualitative difference between P2Y 2 R and M 1 R actions. Ca 2+ release. There are conflicting reports in the literature concerning ryanodine receptors, but our cells responded robustly with a calcium transient upon application of caffeine ( Fig. S7 ), suggesting that tsA-201 cells do express ryanodine receptors and that a more complete model should include them. Hence, although the time course and duration of calcium signals is somewhat graded with stimulus intensity, the peak amplitude rises fairly abruptly, and the range over which the response amplitude is graded is compressed.
There are many published partial models of the IP 3 R. The rationale for design and parameters of our model are detailed in our companion paper. We now consider how our model explains calcium transients in terms that are instructive but quite likely would differ in detail had we chosen another model of the IP 3 R: The calcium response even to short applications of 10 µM Oxo-M is protracted in a late "hump" or plateau (Figs. 2, C and D, and 4 A) . During longer Oxo-M applications (200 s), the response could be reduced and shortened by switching from 2 to 0 mM of extracellular calcium (see Fig. 9 in Horowitz et al., 2005) , a standard test for store-operated calcium entry (SOCE). Our model does not include SOCE. Nevertheless, it does produce a plateau that prolongs the calcium response (Figs. 5 A and 8, B and C) . This plateau results from unanticipated delayed and nonlinear effects of calcium binding to the IP 3 R. In the model, >99.7% of the IP 3 Rs become inactivated within the first second as a consequence of rising calcium ( Fig. S8 A, 1-h 3 ) . Calcium is then gradually cleared through the SERCA pump, and as calcium falls again, a small percentage (0.1%) of receptors recover from inactivation by t = 20 s (while IP 3 is still high), producing a second phase of calcium flux in IP 3 Rs. The resulting calcium plateau represents a dynamic steady state of calcium release and calcium clearance, and its height in our model is determined by the maximum transport capacity of the SERCA pump (vP; Fig. S8 B) . The sub sequent, final decrease in cytosolic calcium is caused by the fall in occupancy of IP 3 -binding sites on the IP 3 R that occurs with declining IP 3 levels. The duration of the calcium response is a function of the apparent affinity of the IP 3 R for IP 3 and was determined primarily by the duration of the IP 3 elevation and by K IP3 (Fig. S8 C) . We conclude that a plateau in the calcium response can result from intrinsic properties of the IP 3 R and is not necessarily a sign of SOCE.
In pharmacological terms, there are spare receptors, a significant receptor reserve, for calcium signaling. Thus, according to our model, 1 nM Oxo-M would occupy only 0.06% of the overexpressed M 1 Rs and activate only 0.3% of the endogenous PLC. As a consequence, 0.1% of the PIP 2 is hydrolyzed per second. In the absence of LIBRAvIII, cytosolic IP 3 would rise to 200 nM after 20 s. This amount is well above the half-activating and modeling into these spatial aspects will be an important next step to further understand how signaling specificity of GqPCR works.
Calcium signaling needs only minimal stimulation of PLC Different signaling end points require different intensities of stimulation of receptors and PLC. For example, M 1 R agonist binding has a midpoint of 4-10 µM for Oxo-M (Jensen et al., 2009 ), yet with high-density M 1 R, closure of KCNQ2/3 channels and FRET interactions between G q and PLC and those between M 1 R and G all have midpoints at 120-330 nM Oxo-M (Jensen et al., 2009) . The release of stored calcium by IP 3 seems to be engaged by the smallest stimulation of receptors and PLC in our tsA cells: (a) Exposure to 1 nM Oxo-M activates PLC sufficiently to evoke a calcium rise, even though it produces too little IP 3 to be detected by the LIBRAvIII IP 3 reporter. (b) Calcium is released by activation of endogenous UTP receptors without a measurable net depletion of plasma membrane PIP 2 . (c) A significant calcium release can be elicited even after depleting much of the normal PIP 2 using exogenous PIP 2 5-phosphatases, whether by rapamycin-induced protein dimerization or by VSP combined with membrane depolarization. These manipulations reduced PIP 2 , and probably IP 3 production, by up to 90% as judged from KCNQ2/3 current inhibition. In drug discovery with overexpressed G q PCRs, calcium measurements are often used as an assay for receptor activation. Such assays should give extremely sensitive responses. The release takes on a somewhat all-or-none character from regenerative positive feedback and occurs at the very low end of receptor occupancy (see below) rather than being broadly graded with receptor activation.
Several factors conspire to allow a small stimulus to make a strong calcium response and for the calcium response to be less graded as a function of agonist concentration. We use ideas from published experiments corroborated by our modeling (see Falkenburger et al., 2013) as an explanation. As is discussed in our companion paper, there are many observations of the IP 3 and calcium dependence of IP 3 R channel opening. They all agree that both IP 3 and calcium show cooperativity, with channel activation following power law dependences (second-fourth power) of their concentrations that steepen the activation curve, as originally described by Bezprozvanny et al. (1991) and reviewed by Foskett et al. (2007) . Calcium also activates PLC, thus accelerating IP 3 production. In our model, IP 3 turns on calcium release with as little as 1% full IP 3 production (which can rise as high as 12 µM IP 3 for the strongest activation). Half-maximal activation of channel opening by 100-300 nM Ca 2+ is augmented by local microdomains of calcium rise around active groups of receptors. Finally, in real cells, but not part of our model, ryanodine receptors on the ER can also add to the Ca 2+ -induced containing several additional proteins (Nakatsu et al., 2012) . As an alternative to PI 4-kinase acceleration, PI(4) P supply might be accelerated during G q PCR activation by increased delivery of PI(4)P to the plasma membrane, for instance, by vesicle trafficking or by the sterol transfer protein Osh4p (de Saint-Jean et al., 2011) from the Golgi.
There are also several types of PIP 5-kinases-1, 1, and 1-that synthesize PI(4,5)P 2 . All are constitutively inhibited by phosphorylation. They are activated by phosphatidic acid, the product of DAG kinase (Kanaho et al., 2007) , activated by the small GTPase RhoA (Oude Weernink et al., 2004) , which can be stimulated by G q PCR (Dutt et al., 2002) , and activated by dephosphorylation through phosphatases that can be stimulated by calcium elevation (Unoki et al., 2012) . Inhibition of Rho facilitated PIP 2 depletion during G q PCR activation in superior cervical ganglion cells (Zaika et al., 2011) . The PIP 5-kinase subtype involved in G q PCR-induced synthesis appears to depend on the cell type (Tolias et al., 2000; Wang et al., 2004 Wang et al., , 2008 .
Although we do not know the biochemical mechanism, our model provides constraints for the time course of the acceleration of PIP 2 synthesis during G q PCR activation. Assuming a very fast onset of acceleration in the model (red trace in Fig. S9 A) produced a transient increase in PIP 2 (red trace in Fig. S9 B) , which we did not observe experimentally when recording KCNQ2/3 current. Therefore, onset may rise with a time constant of 1 s or longer after receptor activation (black traces in Fig. S9 ). However, if it rises very much slower than this, steady state is not reached within 20 s, which also contradicts our experimental findings. Second, if the acceleration of PIP 2 synthesis decays too quickly after agonist wash-off, PIP 2 levels would continue to drop, which we also did not observe. Therefore, acceleration of PIP 2 synthesis may decline with a time constant of 10 s or longer. We tested whether the model would work assuming that resting kinase rates are zero. It did not. We found that PIP 2 recovery after Oxo-M application occurs too quickly (green trace in Fig. S9 ), overshoots, or is insufficient, unless a steady resting value for PI 4-kinase activity is assumed (black trace in Fig. S9 ). Although we did not include it in the model, the acceleration of PIP 2 synthesis might start faster and last longer as the concentration of Oxo-M is raised. Indeed, the model does not fully reproduce the observed difference in response duration between 0.1 and 10 µM Oxo-M for the DAG and IP 3 reporters, and the time constants derived for 10 µM Oxo-M produce the mentioned transients for other concentrations (see Fig. S4 B of our companion paper). Because these findings suggest that kinase acceleration tracks G q PCR activation fairly closely, calcium with its transient and more auto nomous time course is perhaps not as likely to underlie the acceleration of PIP 2 synthesis as, for example, G protein  or  subunits. concentration for IP 3 R calcium release yet below the 500-nM half-saturation concentration for detection by the lower-affinity LIBRAvIII reporter. PIP 2 synthesis must be accelerated during G q PCR activation A couple of seconds after agonist addition, LIBRAvIII starts reporting an increase in IP 3 , and the IP 3 elevation lasts throughout a 200-s agonist application despite the major decline of PIP 2 concentration and KCNQ currents. The IP 3 elevation requires continued PIP 2 synthesis, as it is not maintained after wortmannin treatment, which blocks type III PI 4-kinase. Similar persistent IP 3 production, sensitive to wortmannin, has been shown in experiments with radiolabeled inositol in SH-SY5Y cells (Nakanishi et al., 1995; Willars et al., 1998) . Our standard kinetic model has resting rates for PI 4-kinase and PIP 5-kinase, chosen to match the recovery of PIP 2 both after depletion by PLC and after depletion by VSP (Horowitz et al., 2005; Falkenburger et al., 2010b) . The 5-kinase is 20 times faster than the 4-kinase, making the wortmannin-sensitive PI 4-kinase the rate-limiting enzyme of PIP 2 synthesis. In the model, the mean lifetime of an IP 3 molecule is only 12.5 s, and we find that the chosen resting rates of PIP 2 synthesis are too slow to support the observed persistent IP 3 production during agonist application. These observations require that the rate of the PI 4-kinase be elevated temporarily during G q PCR activation as was done in the model of Xu et al. (2003) .
We have not studied the biochemical mechanism of kinase acceleration. There are several types of PI 4-kinase that synthesize PI(4)P. Shapiro and colleagues found that the inhibition of calcium currents in superior cervical ganglion cells by G q PCR activation, which is attributed to PIP 2 depletion, is facilitated by dominantnegative neuronal calcium sensor 1 (NCS-1) (Gamper et al., 2004; Zaika et al., 2007 Zaika et al., , 2011 . NCS-1 binds calcium and PI 4-kinase III (Zhao et al., 2001) . In PC12 cells, overexpression of NCS-1 increased basal levels of PI(4)P and PI(4,5)P 2 and consequently G q PCR-induced IP 3 production (Koizumi et al., 2002) , suggesting a regulation of constitutive PIP 2 synthesis. The inhibition of receptor-induced responses by wortmannin (Nakanishi et al., 1995) suggests a type III PI 4-kinase, and indeed PIK93, a specific inhibitor of PI 4-kinase III, facilitated inhibition of calcium currents in superior cervical ganglion cells (Zaika et al., 2011) . Yet, PIK93 did not affect IP 3 production by angiotensin or recovery of PI(4)P and PI(4,5)P 2 in HEK293 cells. Instead, PI(4,5)P 2 levels were most strongly depressed during angiotensin application in cells expressing siRNA for PI 4-kinase III (Balla et al., 2008) . Earlier studies had suggested that neither subtype is localized to the plasma membrane (Balla, 2007) , but PI4-kinase III was recently found to be targeted to the plasma membrane by a complex At this point, the major unresolved question for the future is how to introduce acceleration of the lipid kinases into the model in a proven mechanistic manner that depends on other components of the model rather than using an empirical ad hoc time course of acceleration. Such a model should include in a natural way any dependence of acceleration on time and on the strength of receptor activation. In addition the complexities of calcium dynamics, clearance, buffering, and SOCE remain to be included.
Conclusion
Our experiments and modeling have shown that apparent qualitative differences in downstream signaling from muscarinic and purinergic G q PCRs can be understood as entirely caused by differences in receptor density. We also find that a very low threshold for IP 3 -dependent calcium release and the cooperative nature of the release kinetics mean that large, nearly regenerative calcium signals are elicited by quite weak stimulation of G q PCR pathways. Finally, we find that receptor stimulation is accompanied by acceleration of the enzymes of PIP 2 synthesis, but we do not know the underlying mechanism. Our companion paper continues the analysis of DAG production and PKC stimulation and gives further details of our model. We thank Drs. Jill B. Jensen, Martin Kruse, and Byung-Chang Suh for advice and assistance with molecular biology and commenting on the manuscript; Dr. T. Kendall Harden for discussion of P2Y 2 Rs; and Lea M. Miller for technical help.
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